Dow Down0.25% Nasdaq Down0.14%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
10.19 0.29(2.77%) Sep 29, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Sep 30, 2013Jun 30, 2013
Total Revenue -   -   6   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   6   -  
Operating Expenses
Research Development7,450  7,325  4,787  6,037  
Selling General and Administrative1,256  1,226  1,215  1,171  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (8,706) (8,551) (5,996) (7,208)
Income from Continuing Operations
Total Other Income/Expenses Net3  2  (2)1  
Earnings Before Interest And Taxes(8,703)(8,549)(5,998)(7,207)
Interest Expense -   -   -   -  
Income Before Tax(8,703)(8,549)(5,998)(7,207)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(8,703)(8,549)(5,998)(7,207)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (8,703) (8,549) (5,998) (7,207)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (8,703) (8,549) (5,998) (7,207)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.